China Bans BioKangtai Hep B Vaccine Cited In Four Infant Deaths
This article was originally published in PharmAsia News
Executive Summary
China health authorities issued a ban on BioKangtai's recombinant hepatitis B vaccine, citing four infant deaths in three provinces following vaccinations.